These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21322281)

  • 1. [Study of SOD and PON-1 expression in type 2 diabetes mellitus nephropathy and its clinical significance].
    Sun YM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Nov; 26(11):1120-1. PubMed ID: 21322281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
    Sözmen EY; Sözmen B; Delen Y; Onat T
    Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
    Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V
    Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
    Agachan B; Yilmaz H; Karaali Z; Isbir T
    Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The paraoxonase-2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus.
    Mackness B; McElduff P; Mackness MI
    J Intern Med; 2005 Oct; 258(4):363-8. PubMed ID: 16164576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients.
    Nomiyama T; Tanaka Y; Piao L; Nagasaka K; Sakai K; Ogihara T; Nakajima K; Watada H; Kawamori R
    J Hum Genet; 2003; 48(3):138-41. PubMed ID: 12624725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of urinary enzymes in the early diagnosis of diabetic nephropathy].
    Delektorskaia LN; Okunev DIu; Shestakova MV
    Lab Delo; 1990; (7):10-4. PubMed ID: 1699056
    [No Abstract]   [Full Text] [Related]  

  • 11. Association between PON 1 polymorphisms, PON activity and diabetes complications.
    Hofer SE; Bennetts B; Chan AK; Holloway B; Karschimkus C; Jenkins AJ; Silink M; Donaghue KC
    J Diabetes Complications; 2006; 20(5):322-8. PubMed ID: 16949520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of activity, but no decrease in concentration, of erythrocyte Cu,Zn-superoxide dismutase by hyperglycaemia in diabetic patients.
    Kotake M; Shinohara R; Kato K; Hayakawa N; Hayashi R; Uchimura K; Makino M; Nagata M; Kakizawa H; Nakagawa H; Nagasaka A; Itoh M
    Diabet Med; 1998 Aug; 15(8):668-71. PubMed ID: 9702470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme (ACE) activity levels in insulin-independent diabetes mellitus and effect of ACE levels on diabetic patients with nephropathy.
    Ustündağ B; Canatan H; Cinkilinç N; Halifeoğlu I; Bahçecioğlu IH
    Cell Biochem Funct; 2000 Mar; 18(1):23-8. PubMed ID: 10686580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase activity and paraoxonase gene polymorphism in type 2 diabetic patients with or without vascular complications.
    Letellier C; Durou MR; Jouanolle AM; Le Gall JY; Poirier JY; Ruelland A
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):297-304. PubMed ID: 12442067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
    Li C; Gu Q
    Nephrology (Carlton); 2009 Aug; 14(5):514-20. PubMed ID: 19207863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus.
    Ikeda Y; Suehiro T; Inoue M; Nakauchi Y; Morita T; Arii K; Ito H; Kumon Y; Hashimoto K
    Metabolism; 1998 May; 47(5):598-602. PubMed ID: 9591753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of manganese superoxide dismutase gene polymorphism (V16A) with diabetic macular edema in Korean type 2 diabetic patients.
    Lee SJ; Choi MG
    Metabolism; 2006 Dec; 55(12):1681-8. PubMed ID: 17142144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes.
    Tamai M; Furuta H; Kawashima H; Doi A; Hamanishi T; Shimomura H; Sakagashira S; Nishi M; Sasaki H; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 2006 Feb; 71(2):140-5. PubMed ID: 15990193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary N-acetyl-beta-D-glucosaminidase and incipient diabetic nephropathy].
    Wang XD
    Zhonghua Yi Xue Za Zhi; 1988 Apr; 68(4):215-7. PubMed ID: 3196940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.